[Lessons learned from the coxibs' ups and downs. The journals must be tougher against referees and authors].
Läkartidningen, Stockholm. josef.milerad@lakartidningen.se
Josef
J
Milerad
D001319:Authorship; D002986:Clinical Trials as Topic; D016265:Conflict of Interest; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects; D035081:Editorial Policies; D006801:Humans; D017712:Peer Review, Research; D010506:Periodicals as Topic; D017594:Publication Bias
D052246:Cyclooxygenase 2 Inhibitors